Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
Ali Rostami, Mahdi Sepidarkish, Mariska Leeflang, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 3, pp. 331-340
Open Access | Times Cited: 383

Showing 1-25 of 383 citing articles:

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
Christian Holm Hansen, Daniela Michlmayr, Sophie Gubbels, et al.
The Lancet (2021) Vol. 397, Iss. 10280, pp. 1204-1212
Open Access | Times Cited: 642
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
Niklas Bobrovitz, Rahul K. Arora, Christian Cao, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252617-e0252617
Open Access | Times Cited: 239
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 238
SARS‐CoV‐2 re‐infection risk in Austria
Stefan Pilz, Ali Chakeri, John P. A. Ioannidis, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 4
Open Access | Times Cited: 150
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 32-50
Open Access | Times Cited: 145
Current and innovative methods for the diagnosis of COVID‑19 infection (Review)
Luca Falzone, Giuseppe Gattuso, Aristidis Tsatsakis, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 6
Open Access | Times Cited: 139
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Heather Kalish, Carleen Klumpp‐Thomas, Sally Hunsberger, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 601
Open Access | Times Cited: 132
Controlling the pandemic during the SARS-CoV-2 vaccination rollout
João Viana, Christiaan H. van Dorp, Ana Nunes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 126
Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
John P. A. Ioannidis
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 5
Open Access | Times Cited: 120
New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic
Heli Salmi, Santtu Heinonen, Johanna Hästbacka, et al.
Archives of Disease in Childhood (2021) Vol. 107, Iss. 2, pp. 180-185
Closed Access | Times Cited: 117
A look into the future of the COVID-19 pandemic in Europe: an expert consultation
Emil N. Iftekhar, Viola Priesemann, Rudi Balling, et al.
The Lancet Regional Health - Europe (2021) Vol. 8, pp. 100185-100185
Open Access | Times Cited: 117
Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries
Jean B. Nachega, Nadia A. Sam‐Agudu, Rhoderick Machekano, et al.
JAMA Pediatrics (2022) Vol. 176, Iss. 3, pp. e216436-e216436
Open Access | Times Cited: 69
High Asymptomatic Carriage With the Omicron Variant in South Africa
Nigel Garrett, Asa Tapley, Jessica Andriesen, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e289-e292
Open Access | Times Cited: 68
The global prevalence of methicillin-resistant Staphylococcus aureus colonization in residents of elderly care centers: a systematic review and meta-analysis
Amir Hossein Hasanpour, Mahdi Sepidarkish, Abolfazl Mollalo, et al.
Antimicrobial Resistance and Infection Control (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 56
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
N. Ahmad Aziz, Victor M. Corman, Antje K. C. Echterhoff, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 89
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study
Carlos Álvarez-Antonio, Graciela Meza Sánchez, Carlos Calampa, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 7, pp. e925-e931
Open Access | Times Cited: 87
How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic
Sudhvir Singh, Christine McNab, Rose McKeon Olson, et al.
The Lancet (2021) Vol. 398, Iss. 10316, pp. 2109-2124
Open Access | Times Cited: 87
Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children
Soo‐Han Choi, Yoon Hee Jo, Kyo Jin Jo, et al.
Journal of Korean Medical Science (2021) Vol. 36, Iss. 31
Open Access | Times Cited: 83
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis
Ahmed Hossain, Sarker Mohammad Nasrullah, Zarrin Tasnim, et al.
EClinicalMedicine (2021) Vol. 33, pp. 100770-100770
Open Access | Times Cited: 77
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis
Master Chisale, Sheena Ramazanu, Saul Eric Mwale, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 77
Update on SARS-CoV-2 seroprevalence: regional and worldwide
Ali Rostami, Mahdi Sepidarkish, Aylar Fazlzadeh, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1762-1771
Open Access | Times Cited: 70
Racial and Ethnic Disparities in Multisystem Inflammatory Syndrome in Children in the United States, March 2020 to February 2021
Bryan Stierman, Joseph Y. Abrams, Shana Godfred‐Cato, et al.
The Pediatric Infectious Disease Journal (2021) Vol. 40, Iss. 11, pp. e400-e406
Open Access | Times Cited: 62
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya
Isaac Ngere, Jeanette Dawa, Elizabeth Hunsperger, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 25-34
Open Access | Times Cited: 57
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis
İlker Kayı, Bahar Madran, Şiran Keske, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 9, pp. 1242-1249
Open Access | Times Cited: 54
SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis
Reza Naeimi, Mahdi Sepidarkish, Abolfazl Mollalo, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101786-101786
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top